May 02, 2025

Psychotherapy, Family Tied to Better Outcomes

In a large meta-analysis, researchers identified the most effective components of collaborative care for treating depression in primary care.

Conexiant

May 02, 2025

Applications Are Now Open for the 2025 Integrative Oncology Scholars Program and Integrative Oncology Fellows Program

Applications are now being accepted for the 2025 Integrative Oncology Scholars Program and Integrative Oncology Fellows Program at the University of Michigan in Ann Arbor (https://sites.google.com/vie...

The ASCO Post

May 02, 2025

Venetoclax-Based Therapy for Patients With Newly Diagnosed Acute Myeloid Leukemia

Two experts discuss strategies and clinical considerations when treating patients with AML who are ineligible for intensive chemotherapy as well as those who are eligible for intensive chemotherapy.

The ASCO Post

May 02, 2025

Allocate $310 million toward tobacco control, coalition urges

The ADA is urging Congress to fund the Center for Disease Control and Prevention’s Office on Smoking and Health at $310 million in 2026. 

ADA News

May 01, 2025

Phthalates Linked to Cardiovascular Mortality Globally

Researchers linked di-2-ethylhexylphthalate plastic exposure to over 350,000 cardiovascular deaths and 10 million years of life lost, supporting calls for international regulatory measures.

Conexiant

May 01, 2025

Health Care Faces New Immigration Reality

Health care facilities face new challenges as sensitive locations policy protecting them from immigration enforcement was rescinded in January 2025, requiring new protocols for patient protection.

Conexiant

May 01, 2025

DDW 2025: 20-Year Screening Program Drives Down Colorectal Cancer Cases, Deaths

A 20-year initiative that offered flexible options for colorectal cancer screening at a major integrated health system doubled colorectal cancer screening rates, cut cancer incidence by a third, halve...

The ASCO Post

May 01, 2025

Diabetic Retinopathy and Glucagon-Like Peptide-1 Agonists

Glucagon-like peptide-1 agonists (GLP-1), popular choices for the second-line treatment of type 2 diabetes and, most recently, obesity, are connected with diabetic retinopathy.

Optometric Management

May 01, 2025

Semaglutide Shows Potential in Liver Disease Trial

Phase 3 trial finds weekly semaglutide 2.4mg significantly improved liver histology in patients with MASH and moderate to advanced fibrosis.

Conexiant